✦ LIBER ✦

Metastatic malignant melanoma in a patient taking interleukin-1 receptor antagonist

✍ Scribed by Daniel Wendling; François Aubin

Book ID: 113684047
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 104 KB
Volume: 73
Category: Article
ISSN: 1297-319X
DOI: 10.1016/j.jbspin.2005.08.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MDR-1 Expression in Metastatic Malignant

MDR-1 Expression in Metastatic Malignant Melanoma

✍ Edward A. Levine; Tatyana A. Holzmayer; Igor B. Roninson; Tapas K. Das Gupta 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 254 KB

Prognostic factors in patients with meta

Prognostic factors in patients with metastatic malignant melanoma: A multivariate analysis

✍ Matthew N. Sirott; Dean F. Bajorin; George Y. C. Wong; Yue Tao; Paul B. Chapman; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 780 KB

A phase II study of bryostatin 1 in meta

A phase II study of bryostatin 1 in metastatic malignant melanoma

✍ Propper, DJ; Macaulay, V; O'Byrne, KJ; Braybrooke, JP; Wilner, SM; Ganesan, TS; 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 825 KB

Safety profile of histamine dihydrochlor

Safety profile of histamine dihydrochloride administered with interleukin-2 in patients with advanced metastatic malignant melanoma

✍ S.J. O'Day; J. Glaspy; E. Whitman; C.L. Kass; K.R. Gehlsen; S.S. Agarwala 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 180 KB

A phase II study of spirogermanium in pa

A phase II study of spirogermanium in patients with metastatic malignant melanoma

✍ Elizabeth Eisenhauer; Ian Kerr; Audley Bodurtha; Neill Iscoe; Peter McCulloch; K 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 205 KB

The National Cancer Institute of Canada Clinical Trials Group conducted a phase II study of spirogermanium given daily for 5 days every 3 weeks to previously untreated patients with malignant melanoma. In 21 evaluable patients one complete response was seen (response rate 5%). Disease progression oc

Study of IL-2 receptor expression after

Study of IL-2 receptor expression after chemoimmunotherapy in patients treated for metastatic malignant melanoma

✍ R. MOUAWAD; M. ICHEN; O. RIXE; A. BENHAMMOUDA; E. VUILLEMIN; M. WEIL; D. KHAYAT; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB